Search results
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 5 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 2 days agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 2 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine, mRNA-1345.
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoProofPilot, the industry's premier platform for patient & site automation, guidance, and seamless execution, announces today its double victory alongside esteemed partner Moderna< ...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 5 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 5 days agoModerna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for...
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 3 days agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Russell Investments Group Ltd.
ETF DAILY NEWS· 6 days agoRussell Investments Group Ltd. cut its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 28.3% during the 4th quarter, according to its most recent Form 13F ...
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
Barrons.com· 5 days agoThe agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 5 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...